Loading...

HLHS Trials And Aging Demographics Will Expand Regenerative Markets

Published
17 Aug 25
n/a
n/a
AnalystHighTarget's Fair Value
n/a
Loading
1Y
-64.6%
7D
-14.2%

Author's Valuation

US$10.4592.7% undervalued intrinsic discount

AnalystHighTarget Fair Value